Lanatozid C

Lanatozid C
Lanatozid CLanatozid CLanatozid CLanatozid C
Cardiovascular System
Albania
No
Yes
No
SA00218
Lanatozid C
(0.02%) 0.4 mg/2 ml
Solution for injection
Lanatoside C
Box x 10 ampoules
Solution for injection - (0.02%) 0.4 mg/2 ml Lanatozid C is a cardiac glycoside with positive inotropic effect. Its effects are similar with digoxin. … Read more

Solution for injection - (0.02%) 0.4 mg/2 ml

Lanatozid C is a cardiac glycoside with positive inotropic effect. Its effects are similar with digoxin. It increases the myocardial contraction strength and decreases myocardial conductivity, especially the conductivity through the AV node.

Lanatozid C exerts positive inotropic effect and negative chronotropic effect.

Approximately 20% of the used dose is inactivated within 24 hours. Its effects disappear after 3 – 6 days. Digoxin is the metabolite of lanatoside C and it is eliminated through urine.

Lanatozid C is indicated in:

  • the treatment of mild to moderately severe heart failure
  • the treatment of paroxysmal supraventricular tachycardia.

Recently viewed

Solution for injection - ( 0.1%) 1 mg/1 ml

Adrenaline is an endogenous substance that is produced in the adrenal medulla and has important physiological effects. It is a potent agonist at both alpha and beta adrenoceptors, although the effect on beta adrenoceptors is more marked, particularly at lower doses.

 The major effects of adrenaline are dose-related and include:

dilatation of the bronchi, narrowing of blood vessels, increased heart rate and contractility (positive chronotropic and inotropic effect) and stimulation at central level. Adrenaline is a histamine antagonist. It is used for the treatment of life emergencies.

Adrenaline is used in acute allergic reactions and anaphylactic shock.

It is also used in advanced cardiac life support.

Tablets - 25 mg

Tablets - 200 mg

Tablets - 10 mg

Solution for injection - (0.1%) 1 mg/1 ml